Stockreport

Intellia Therapeutics, Inc.'s (NASDAQ:NTLA) latest 6.7% decline adds to one-year losses, institutional investors may consider drastic measures [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF 51% of the business is held by the top 10 shareholders Insiders have sold recently A look at the shareholders of Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) can tel [Read more]